News

Worse Survival Seen With Chemo Dose Reduction in Ovarian Cancer

Chemotherapy dose reduction is associated with worse survival in ovarian cancer, according to a study published in JAMA Oncology.

Case Study: Vitamin K Deficiency Result of Vaccine Refusal

Fussy infants with unexplained bruising or bleeding may have late-onset vitamin K-deficient bleeding (VKDB) as a result of parental refusal of the vitamin K injection at birth.

Prescription Drug Monitoring Programs Offer Multiple Benefits

Prescription Drug Monitoring Programs (PDMPs), frequently utilized by emergency medicine physicians and designed to help identify patients who "doctor shop" for prescriptions, are used to guide clinical decisions and opioid prescribing, as well as to facilitate discussions and provide patient education. .

Asian-Language Smoking Quitline Successful Nationwide

An Asian-Language Smokers Quitline (ASQ) reaches Chinese, Korean, and Vietnamese speakers nationwide, and most callers receive medication and counseling, according to a study published in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

Health Professionals May View Family-Witnessed CPR Negatively

Jordanian health care professionals are against family-witnessed resuscitation in adult critical care settings, according to a study published in the Journal of Clinical Nursing.

Statins Linked to Aggression in Women, But Not Men

The effect of statins on aggression appears to differ based on sex and age, as a study published in PLOS ONE found that aggression increased in postmenopausal women taking statins but actually decreased in men.

FDA Approves Unique Treatment for Cystic Fibrosis

The Food and Drug Administration (FDA) has approved Orkambi (lumacaftor/ivacaftor; Vertex), the first and only drug indicated for the treatment of cystic fibrosis (CF) in patients aged ≥12 who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Regional Variation in Treatment of Ischemic Stroke

Region accounted for 7 to 8 percent of variation in thrombolysis treatment

Afamelanotide Beneficial in Erythropoietic Protoporphyria

Improvement in number of hours of direct exposure to sunlight without pain, quality of life

Study Shows Saxenda Tied to Reduction in Body Weight

Beneficial effect for once-daily subcutaneous injection, together with lifestyle counseling